Sil P, Sen S
Department of Molecular Cardiology, Research Institute, The Cleveland Clinic Foundation Ohio 44195, USA.
Hypertension. 1997 Aug;30(2 Pt 1):209-16. doi: 10.1161/01.hyp.30.2.209.
Angiotensin II (Ang II) has been implicated in stimulating myocyte growth in vitro, but the mechanism for such stimulation is still an open question. To understand the role of Ang II, we studied its effect on protein synthesis in rat neonatal and adult myocytes. Ang II (10(-8) mol/L) stimulated protein synthesis in neonatal myocytes by 43+/-3.5% over control. To prevent the proliferation of fibroblasts, bromodeoxyuridine was added, and protein synthesis in neonatal myocytes was reduced to 21+/-2.2% over control. In adult myocytes (cultured without bromodeoxyuridine), Ang II stimulated [3H]leucine incorporation by 24+/-2.3% over control; with bromodeoxyuridine, that stimulation was reduced significantly (13+/-0.93% over control). These data suggest that the presence of fibroblasts in the cultures may control myocyte growth. When supernatant from pure fibroblast culture was added to myocyte preparations, a significant increase (49.8+/-3.5% over control) in protein synthesis occurred. Pretreatment of these fibroblasts with Ang II (10(-3) mol/L) further stimulated protein synthesis, suggesting that Ang II directly stimulates the production of a factor from fibroblasts. The stimulatory effect of Ang II on the release of the factor can be completely blocked by pretreatment with losartan, an Ang II receptor (AT1) blocker. Our data are the first to demonstrate a paracrine effect of a fibroblast-derived factor that modulates myocyte growth. Fibroblast-derived factor loses its biological activity by (1) tryptic digestion, (2) exposure to pH below 4.0 and above 9.0, and (3) heating to 95 degrees C. The molecular weight of the factor is approximately 65 kD. The antibodies against fibroblast growth factor (both acidic and basic) could not inhibit this factor's stimulatory effect. Furthermore, this factor is heart specific and is produced at least up to the 16th passage of neonatal rat heart fibroblasts. Skin fibroblasts, aortic endothelial cells, and aortic smooth muscle cells do not produce this protein. Our data suggest that the observed myocyte growth by Ang II comes about via fibroblast-derived factor, which is increased by Ang II. Cross talk between fibroblasts and myocytes is an important factor in stimulating myocyte growth by Ang II.
血管紧张素II(Ang II)已被证实可在体外刺激心肌细胞生长,但其刺激机制仍是一个悬而未决的问题。为了了解Ang II的作用,我们研究了其对新生大鼠和成年大鼠心肌细胞蛋白质合成的影响。Ang II(10^(-8) mol/L)使新生心肌细胞的蛋白质合成比对照组增加了43±3.5%。为防止成纤维细胞增殖,加入了溴脱氧尿苷,新生心肌细胞的蛋白质合成比对照组降至21±2.2%。在成年心肌细胞(无溴脱氧尿苷培养)中,Ang II使[3H]亮氨酸掺入量比对照组增加了24±2.3%;加入溴脱氧尿苷后,这种刺激作用显著降低(比对照组增加13±0.93%)。这些数据表明,培养物中存在的成纤维细胞可能控制心肌细胞的生长。当将纯成纤维细胞培养物的上清液添加到心肌细胞制剂中时,蛋白质合成显著增加(比对照组增加49.8±3.5%)。用Ang II(10^(-3) mol/L)预处理这些成纤维细胞可进一步刺激蛋白质合成,表明Ang II直接刺激成纤维细胞产生一种因子。Ang II对该因子释放的刺激作用可被Ang II受体(AT1)阻滞剂氯沙坦预处理完全阻断。我们的数据首次证明了成纤维细胞衍生因子的旁分泌作用,该因子可调节心肌细胞生长。成纤维细胞衍生因子通过以下方式失去其生物活性:(1)胰蛋白酶消化,(2)暴露于pH低于4.0或高于9.0的环境,(3)加热至95℃。该因子的分子量约为65 kD。抗成纤维细胞生长因子(酸性和碱性)的抗体均不能抑制该因子的刺激作用。此外,该因子具有心脏特异性,至少在新生大鼠心脏成纤维细胞传至第16代时仍能产生。皮肤成纤维细胞、主动脉内皮细胞和主动脉平滑肌细胞不产生这种蛋白质。我们的数据表明,观察到的Ang II诱导的心肌细胞生长是通过成纤维细胞衍生因子实现的,该因子由Ang II增加。成纤维细胞与心肌细胞之间的相互作用是Ang II刺激心肌细胞生长的一个重要因素。